| Synonyms: | |
| Status: | Approved (1951) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | D04AA10 |
| UNII: | FF28EJQ494 |
| InChI Key | PWWVAXIEGOYWEE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H20N2S |
| Molecular Weight | 284.43 |
| AlogP | 4.24 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 6.48 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 20.0 |
| Primary Target | |
|---|---|
| H1 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 6900 | - | - | 61 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | 100 | - | - | 84 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | 5 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | 23 | - | - | - | |
|
Surface antigen
|
8000 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 7590 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 35100 | - | - | 71 | |
|
Transporter
|
- | 17700 | - | - | 71 | |
|
Unclassified protein
|
- | 60000 | 50000 | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pain | 3 | D010146 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Migraine with Aura | 3 | D020325 | ClinicalTrials |
| Migraine without Aura | 3 | D020326 | ClinicalTrials |
| Hyperemesis Gravidarum | 3 | D006939 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Nausea | 3 | D009325 | ClinicalTrials |
| Vertigo | 3 | D014717 | ClinicalTrials |
| Vomiting | 3 | D014839 | ClinicalTrials |
| Gastroparesis | 2 | D018589 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 60-87-7 |
| ChEBI | 8461 |
| ChEMBL | CHEMBL643 |
| DrugBank | DB01069 |
| DrugCentral | 2286 |
| EPA CompTox | DTXSID7023518 |
| FDA SRS | FF28EJQ494 |
| Human Metabolome Database | HMDB0015202 |
| Guide to Pharmacology | 7282 |
| KEGG | C07404 |
| PharmGKB | PA451128 |
| PubChem | 4927 |
| SureChEMBL | SCHEMBL4700 |